BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 22070372)

  • 1. Active surveillance criteria for prostate cancer: can they be applied to Japanese patients?
    Goto Y; Nozumi K; Miyazaki K; Matsumoto A; Inoue A; Kito H; Hasegawa N; Nagata M; Kakuta Y; Suzuki H; Yamaguchi K
    Int J Urol; 2012 Feb; 19(2):163-6. PubMed ID: 22070372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of pathological outcomes of active surveillance candidates who underwent radical prostatectomy using contemporary protocols at a high-volume Korean center.
    Lee DH; Jung HB; Lee SH; Rha KH; Choi YD; Hong SJ; Yang SC; Chung BH
    Jpn J Clin Oncol; 2012 Nov; 42(11):1079-85. PubMed ID: 22988037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathological outcomes of candidates for active surveillance of prostate cancer.
    Conti SL; Dall'era M; Fradet V; Cowan JE; Simko J; Carroll PR
    J Urol; 2009 Apr; 181(4):1628-33; discussion 1633-4. PubMed ID: 19233388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical management after active surveillance for low-risk prostate cancer: pathological outcomes compared with men undergoing immediate treatment.
    Dall'Era MA; Cowan JE; Simko J; Shinohara K; Davies B; Konety BR; Meng MV; Perez N; Greene K; Carroll PR
    BJU Int; 2011 Apr; 107(8):1232-7. PubMed ID: 20804478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What percentage of patients with newly diagnosed carcinoma of the prostate are candidates for surveillance? An analysis of the CaPSURE database.
    Barocas DA; Cowan JE; Smith JA; Carroll PR;
    J Urol; 2008 Oct; 180(4):1330-4; discussion 1334-5. PubMed ID: 18707731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management and survival of screen-detected prostate cancer patients who might have been suitable for active surveillance.
    Roemeling S; Roobol MJ; Postma R; Gosselaar C; van der Kwast TH; Bangma CH; Schröder FH
    Eur Urol; 2006 Sep; 50(3):475-82. PubMed ID: 16713065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active Surveillance is an Appropriate Management Strategy for a Proportion of Men Diagnosed with Prostate Cancer by Prostate Specific Antigen Testing.
    Overholser S; Nielsen M; Torkko K; Cwilka D; Weaver B; Shi X; Leach RJ; Hernandez J; Huang T; Thompson IM; Thompson IM
    J Urol; 2015 Sep; 194(3):680-4. PubMed ID: 25636657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does initial surveillance in early prostate cancer reduce the chance of cure by radical prostatectomy?--A case control study.
    Khatami A; Damber JE; Lodding P; Pihl CG; Hugosson J
    Scand J Urol Nephrol; 2003; 37(3):213-7. PubMed ID: 12775279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical predictors of Gleason score upgrading: implications for patients considering watchful waiting, active surveillance, or brachytherapy.
    Kulkarni GS; Lockwood G; Evans A; Toi A; Trachtenberg J; Jewett MA; Finelli A; Fleshner NE
    Cancer; 2007 Jun; 109(12):2432-8. PubMed ID: 17497649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathological findings and prostate specific antigen outcomes after radical prostatectomy in men eligible for active surveillance--does the risk of misclassification vary according to biopsy criteria?
    Ploussard G; Salomon L; Xylinas E; Allory Y; Vordos D; Hoznek A; Abbou CC; de la Taille A
    J Urol; 2010 Feb; 183(2):539-44. PubMed ID: 20006888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active surveillance for the management of prostate cancer in a contemporary cohort.
    Dall'Era MA; Konety BR; Cowan JE; Shinohara K; Stauf F; Cooperberg MR; Meng MV; Kane CJ; Perez N; Master VA; Carroll PR
    Cancer; 2008 Jun; 112(12):2664-70. PubMed ID: 18433013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient selection and pathological outcomes using currently available active surveillance criteria.
    El Hajj A; Ploussard G; de la Taille A; Allory Y; Vordos D; Hoznek A; Abbou CC; Salomon L
    BJU Int; 2013 Aug; 112(4):471-7. PubMed ID: 23746382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eligibility for active surveillance and pathological outcomes for men undergoing radical prostatectomy in a large, community based cohort.
    Smaldone MC; Cowan JE; Carroll PR; Davies BJ
    J Urol; 2010 Jan; 183(1):138-43. PubMed ID: 19913808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer detection and cancer characteristics in the European Randomized Study of Screening for Prostate Cancer (ERSPC)--Section Rotterdam. A comparison of two rounds of screening.
    Postma R; Schröder FH; van Leenders GJ; Hoedemaeker RF; Vis AN; Roobol MJ; van der Kwast TH
    Eur Urol; 2007 Jul; 52(1):89-97. PubMed ID: 17257742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uncertainty and quality of life among men undergoing active surveillance for prostate cancer in the United States and Ireland.
    Hegarty JM; Wallace M; Comber H
    Am J Mens Health; 2008 Jun; 2(2):133-42. PubMed ID: 19477777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathological findings at radical prostatectomy in Japanese prospective active surveillance cohort.
    Sugimoto M; Shiraishi T; Tsunemori H; Demura T; Saito Y; Kamoto T; Kakehi Y
    Jpn J Clin Oncol; 2010 Oct; 40(10):973-9. PubMed ID: 20534686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A contemporary study correlating prostate needle biopsy and radical prostatectomy Gleason score.
    Fine SW; Epstein JI
    J Urol; 2008 Apr; 179(4):1335-8; discussion 1338-9. PubMed ID: 18289601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-adjusted validation of the most stringent criteria for active surveillance in low-risk prostate cancer patients.
    Suardi N; Gallina A; Capitanio U; Salonia A; Lughezzani G; Freschi M; Mottrie A; Rigatti P; Montorsi F; Briganti A
    Cancer; 2012 Feb; 118(4):973-80. PubMed ID: 21751185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Under staging and under grading in a contemporary series of patients undergoing radical prostatectomy: results from the Cancer of the Prostate Strategic Urologic Research Endeavor database.
    Grossfeld GD; Chang JJ; Broering JM; Li YP; Lubeck DP; Flanders SC; Carroll PR
    J Urol; 2001 Mar; 165(3):851-6. PubMed ID: 11176485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Editorial Comment to Active surveillance criteria for prostate cancer: can they be applied to Japanese patients?
    Suzuki M
    Int J Urol; 2012 Feb; 19(2):167-8. PubMed ID: 22092371
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.